Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Turgut, Huseyin ^a   Sacar, Suzan ^a   Kaleli, Ilknur ^a   Sacar, Mustafa ^a   Goksin, Ibrahim ^a   Toprak, Semra ^a   Asan, Ali ^a   Cevahir, Nural ^a   Tekin, Koray ^a   Baltalarli, Ahmet ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DACRON; LEVOFLOXACIN; METICILLIN; POLITEF; TEICOPLANIN; ANTIINFECTIVE AGENT; OFLOXACIN; POLYETHYLENE TEREPHTHALATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; CONTROLLED STUDY; DRUG EFFICACY; FREQUENCY ANALYSIS; GRAFT INFECTION; GROWTH INHIBITION; IN VIVO STUDY; INFECTION PREVENTION; INOCULATION; MALE; NONHUMAN; PROSTHESIS MATERIAL; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; RISK REDUCTION; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; SUBCUTANEOUS TISSUE; ANIMAL; BLOOD VESSEL TRANSPLANTATION; DRUG EFFECT; INFECTION; MICROBIOLOGY; PENICILLIN RESISTANCE; WISTAR RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; MALE; METHICILLIN RESISTANCE; OFLOXACIN; POLYETHYLENE TEREPHTHALATES; POLYTETRAFLUOROETHYLENE; PROSTHESIS-RELATED INFECTIONS; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TEICOPLANIN;

EID: 27744506191     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-91     Document Type: Article

References (48)

1. Soetevent C, Klemm PL, Stalenhoef AF, Bredie SJ. Vascular graft infection in aortoiliac and aortofemoral bypass surgery: clinical presentation, diagnostic strategies and results of surgical treatment. Neth J Med 2004, 62(11):446-52.
2. Bunt TJ. Vascular graft infections: an update. J Cardiovasc Surg 2001; 9(3):225-233.
3. Jones L, Braithwaite BD, Davies B, Heather BP, Earnshaw JJ: Mechanism of late prosthetic vascular graft infection. J Cardiovasc Surg 1997; 5(5):486-489.
4. Bergamini TM, Corpus RA, Brittian KR, Peyton JC, Cheadle WG: The natural history of bacterial biofilm graft infection. J Surg Res 1994, 56:393-396.
5. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S: Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 2002, 23(12):716-20.
6. Mingoli A, Sapienza P, Di Marzo L, Sgarzini G, Burchi C, Modini C, Cavallaro A: Management of abdominal aortic prosthetic graft infection requiring emergent treatment. Angiology 1997, 48(6):491-495.
7. Seeger JM, Pretus HA, Welborn MB, Ozaki CK, Flynn TC, Huber TS: Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg 2000, 32(3):451-461.
8. Abdulrahman IS, Al-Mueilo SH, Bokhary HA, Ladipo GOA, Al-Rubaish A: A prospective study of hemodialysis access-related bacterial infections. J Infect Chemother 2002, 8:242-246.
9. Liekwig WG, Greenfield LJ: Vascular graft infection: collected experience and results of treatment. Surgery 1977, 81:335-342.
10. Ghiselli R, Giacometti A, Cirioni O, Mocchegiani F, Orlando F, Del Prete MS, D'Amato G, Scalise G, Saba V: Quinopristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted plyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. Eur J Vasc Endovasc Surg 2002, 24:230-234.
11. Giacometti A, Cirioni O, Ghiselli R; Goffi L, Moccheigiani F, Riva A, Scalise G, Saba V: Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidemidis. J Antimicrob Chemother 2000, 46:751-756.
12. Hasselgren PO, Ivarsson L, Risberg B, Sheeman T: Effects of prophylactic antibiotics in vascular surgery. A prospective randomised double blind study. Ann Surg 1984, 200:86-92.
13. Hennes N, Sandmann W, Torsello G, Kniemeyer HW, Grabitz K: Infection of a vascular prosthesis-a retrospective analysis of 99 cases. Chirurg 1996, 67(1):37-43.
14. Casellas JM, Gilardoni M, Tomè G, Goldberg M, Ivanovich S, Orduna M, Dolmann A, Ascoli M, Ariza H, Montero JM: Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections. J Antimicrob Chemother 1999; 43(3):37-42.
15. Soussy C J, Cluzel M, Ploy M C, Kitzis MD, Morel C, Bryskier A, Courvalin P: In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study. J Antimicrob Chemother 1999, 43(3):43-50.
16. Pauluzzi S, Del Favero A, Menichetti F, Barrata E, Moretti VM, Di Fillipo F, Pasticci MB, Guerciolini R, Patoia L, Frongillo RF: Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study. J Antimicrob Chemother 1987, 20:431-438.
17. De Lalla F, Santoro D, Rinaldi E, Suter F, Cruciani M, Guaglianone MH, Rizzardini G, Pellegata G: Teicoplanin in the treatment of infections by staphylococci, Clostridium difficil and other gram-positive bacteria. J Antimicrob Chemother 1989, 23:131-142.
18. Thomas A, Campbell GR, Campbell JH: Advances in vascular tissue engineering. Cardiovasc Pathol 2003, 12:271-276.
19. Schmitt DD, Bandyk DF, Pequet AJ, Towne JB. Bacterial adherence to vascular protheses. J Vasc Surg 1986, 3(5):732-40.
20. Institute of Laboratory Animal Resources National Research Council. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press; 1996.
21. Kloos WE, Barnerman TL: Staphylococcus and Micrococcus. In Manual of Clinical Microbiology. 7th edition. Edited by Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Washington: ASM Press; 1999:264-277.
22. Lenhgharardit F J, Torsello G, Claeys L G Y, Pfeiffer M, Wachol-Drewek Z, Grundmann RT, Sandmann W: Systemic and local antibiotic prophylaxis in the prevention of prosthetic vascular graft infection: an experimental study. Eur J Vasc Surg 2002, 23:127-133.
23. Ghiselli R, Giacometti A, Goffi L, Cirioni O, Boccoli G, Mocchegiani F, Riva A, Scalise G, Saba V: Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. Eur J Vasc Endovasc Surg 2000, 20(6):508-511.
24. Ghiselli R, Giacometti A, Goffi L, Cirioni O, Mocchegaiani F, Orlando F, Paggi AM, Petrelli E, Scalise G, Saba V. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed Dacron. J Surg Res 2001, 99:316-320.
25. Sladen JG, Chen JC, Reid JDS: An aggresive local approach to vascular graft infection. Am J Surg 1998, 176: 222-225.
26. Bandyk DF, Berni GA, Thiele BL, Towne JB: Aortofemoral graft infection due to Staphylococcus epidemidis. Arch Surg 1984, 119(1):102-108.
27. Murase K, Hirose H, Mori Y, Takagi H, Iwata H, Sago T, Kawamura Y: Graft-preserving treatment for vascular graft infected with Staphylococcus aureus with antibiotic-releasing porous apatite ceramic in the rabbit. J Vasc Surg 2003, 38:368-73.
28. Woodford N, Johnson AP, Mirrison D, Speller DCE: Current perspectives on glycopeptide resistance. Clin Microbiol Rev 1995, 8(4):585-615.
29. Lim SH, Smith MP, Salooja N, Machin SJ, Goldstone AH: A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. J Antimicrob Chemother 1991, 28:109-116.
30. De Lalla F, Viola R, Pellizzer G, Lazzarini L, Tramarin A, Fabris P: Regional prophylaxis with teicoplanin in monolateral or bilateral total knee replacement: an open study. Antimicrob Agents Chemother 2000, 44(2):316-319.
31. Marroni M, Cao P, Fiorio M, Maghini M, Lenti M, Repeto A, Menichetti F: Prospective, randomized, double-blind trial comparing teicoplanin and cefazolin as antibiotic prophylaxis in prosthetic vascular surgery. Eur J Clin Microbiol Infect Dis 1999, 18(3):175-178.
32. Suter F, Avai A, Bottura P, Fusco U, Gerundini M, Caprioli S, Maggiolo F: Teicoplanin versus cefamandole in the prevention of infection in total hip replacement. Eur J Clin Microbiol Infect Dis 1994, 13(10):793-796.
33. Antrum RM, Bibby SR, Ramsden CH, Kester RC: Teicoplanin: part I. An evaluation of the concentrations seen in serum and the subcutaneous fat of the relatively ischaemic limb following a single intravenous bolus. Drugs Exp Clin Res 1989, 15: 21-23.
34. Kester RC, Antrum R, Thornton CA, Ramsdenf CH, Harding I: A comparison of teicoplanin versus cephradine plus metronidazole in the prophylaxis of post-operative infection in vascular surgery. J Hosp Infect 1999, 41:233-243.
35. Von Eiff C, Peters G: In-vitro activity of ofloxacin, levofloxacin and D-ofloxacin against staphylococci. J Antimicrob Chemother 1996, 38:259-263.
36. Gesu G P, Marchetti F, Piccoli L, Cavallero A: Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories. Antimicrob Agents Chemother 2003, 47(2):816-819.
37. Chambers HF, Xiang Liu Q, Liuxin Chow L, Hackbarth C: Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus. Antimicrob Agents Chemother 1999, 43:2742-2746.
38. Von Baum H, Böttcher S, Hoffmann H, Sonntag HG: Tissue penetration of a single dose of levofloxacin intravenously for antibiotic prophylaxis in lung surgery. JAC 2001, 13 (5):729-730.
39. Swoboda S, Oberdorfer K, Klee F, Hoppe-Tichy T, von Baum H, Geiss HK: Tissue and serum concentrations of levofloxacin 500 mg administered intravenously or orally for antibiotic prophylaxis in biliary surgery. JAC 2003, 51:459-462.
40. Hernandez-Richter T, Schardey H M, Wittmann F, Mayr S, Schmitt-Sody M, Blasenbreu S, Heiss MM, Gabka C, Angele MK: Rifampin and triclosan but not silver is effective in preventing bacterial infection of vascularDacron graft material. Eur J Vasc Surg 2003; 26:550-557.
41. Giacometti A, Cirioni O, Ghiselli R, Goffi L, Viticchi C, Mocchegiani F, Riva A, Orlando F, Saba V, Scalise G: Mupirocin prophylaxis against methicillin susceptible, methicillin-resistant or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. Antimicrob Agents Chemother 2000, 44(10):2842-2844.
42. Ghiselli R, Giacometti A, Cirioni O, Mocchegiani F, Orlando F, Kamysz W, Del Prete MS, Lukasiak J, Scalise G, Saba V: Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. J Vasc Surg 2002, 36:1027-30.
43. Dell'Acqua G, Giacometti A, Cirioni O, Ghiselli R, Saba V, Scalise G, Gov Y, Balaban N: Suppression of drug-resistant staphylococcal infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. J Infect Dis 2004; 190(2):318-320.
44. Osada T, Yamamura K, Fujimoto K, Mizuno K, Sakurai T, Ohta M, Nabeshima T: Prophylaxis of local vascular graft infection with levofloxacin incorporated into albumin-sealed dacron graft (LVFX-ALB Graft). Microbiol Immunol 1999, 43(4):317-21.
45. Galdbart J O, Branger C, Andreassian B, Lambert-Zechovsky N, Kitzis M: Elution of six antibiotics bonded to polyeyhylene vascular grafts sealed with three proteins. J Surg Res 1996, 66:174-178.
46. Falkenback D, Lundberg F, Ribbe E, Ljungh A: Exposure of plasma proteins on Dacron and ePTFE vascular material in a perfusion model. Eur J Vasc Surg 2000, 19: 468-475.
47. Malangoni M A, Livingston D H, Peyton J C: Of protein Binding on the adherence of staphylococci to prosthetic vascular grafts. J Surg Res 1993, 54:168-172.
48. Camiade C, Goldschmidt P, Koskas F, Ricco JB, Jarraya M, Gerota J, Kieffer E: Optimization of the resistance of arterial allografts to infection: comparative study with synthetic prostheses. Ann Vasc Surg 2001, 15:186-196.